CT volume/density ratio as the marker of ischaemic brain injury

Acta Neurologica Scandinavica

Volumn 123, Issue 5, 2011, Pages 310-315

  Kurzepa, J ^a   Bielewicz, J ^a   Czekajska Chehab, E ^a   Bartosik Psujek, H ^a   Grabarska, A ^a   Stelmasiak, Z ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Barthel index; Computed tomography; Ischaemic stroke; Matrix metalloproteinase 9; Modified rankin scale; NIHSS; S100BB

Indexed keywords

GELATINASE A; GELATINASE B; PROTEIN S100B;

ADULT; AGED; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN TISSUE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ENZYME ACTIVITY; FEMALE; FUNCTIONAL DISEASE; HOSPITALIZATION; HUMAN; MALE; NEUROLOGIC EXAMINATION; RANKIN SCALE;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CONE-BEAM COMPUTED TOMOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NERVE GROWTH FACTORS; NEUROLOGIC EXAMINATION; PATIENT SELECTION; RECOVERY OF FUNCTION; S100 PROTEINS; STROKE;

EID: 79952858015     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01392.x     Document Type: Article

References (24)

1. De Lucas EM, Sánchez E, Gutiérrez A et al. CT protocol for acute stroke: tips and tricks for general radiologists. Radiographics 2008;28:1673-87.
2. Nakano S, Iseda T, Yoneyama T et al. Early CT signs in patients with acute middle cerebral artery occlusion: incidence of contrast staining and haemorrhagic transformations after intra-arterial reperfusion therapy. Clin Radiol 2006;61:156-62.
3. Kurien J, Singhal P, Cook C. Evolution of changes in the computed tomography scans of the brain of a patient with left middle cerebral artery infarction: a case report. J Med Case Rep 2008;2:148-51.
4. Warlow C, Sudlow C, Dennis M et al. Stroke. Lancet 2003;362:1211-24.
5. De Reuck J, Van de Velde E, Van Maele G et al. The prognostic significance of changes in X-ray attenuation on CT in established cerebral infarcts. Cerebrovasc Dis 2003;16:114-21.
6. Higano S, Uemura K, Shishido F et al. Evaluation of critically perfused area in acute ischemic stroke for therapeutic reperfusion: a clinical PET study. Ann Nucl Med 1993;7:167-71.
7. Sotgiu S, Zanda B, Marchetti B et al. Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol 2006;13:505-13.
8. Rodríguez-Yáñez M, Castellanos M, Sobrino T et al. Molecular markers are associated with early computed tomography ischemic changes. Neurologia 2008;23:220-5.
9. Modrego PJ, Boned B, Berlanga JJ et al. Plasmatic B-type natriuretic peptide and C-reactive protein in hyperacute stroke as markers of CT-evidence of brain edema. Int J Med Sci 2008;13:18-23.
10. Castillo J, Rodriguez I. Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis 2004;17(Suppl. 1):7-18.
11. Sen J, Belli A. S100B in neuropathologic states: the CRP of the brain? J Neurosci Res 2007;85:1373-80.
12. Abraha HD, Butterworth RJ, Bath PM et al. Serum S-100 protein, relationship to clinical outcome in acute stroke. Ann Clin Biochem 1997;34:546-50.
13. Petzold A, Michel P, Stock M et al. Glial and axonal body fluid biomarkers are related to infarct volume, severity, and outcome. J Stroke Cerebrovasc Dis 2008;17:196-203.
14. Kurzepa J, Stryjecka-Zimmer M. The effect of interferon beta-1a on MMP-2 and MMP-9 proteolytic activity. Folia Biol (Praha) 2007;53:220-1.
15. Liebeskind DS. Imaging the future of stroke: I. Ischemia. Ann Neurol 2009;66:574-90.
16. Hoggard N, Wilkinson ID, Griffiths PD. The imaging of ischaemic stroke. Clin Radiol 2001;56:171-83.
17. Wang M, Etu J, Joshi S. Enhanced disruption of the blood brain barrier by intracarotid mannitol injection during transient cerebral hypoperfusion in rabbits. J Neurosurg Anesthesiol 2007;19:249-56.
18. Wiesmann M, Steinmeier E, Magerkurth O et al. Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP. Acta Neurol Scand 2010;121:178-85.
19. Park KP, Rosell A, Foerch C et al. Plasma and brain matrix metalloproteinase-9 after acute focal cerebral ischemia in rats. Stroke 2009;40:2836-42.
20. Shigemori Y, Katayama Y, Mori T et al. Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats. Acta Neurochir Suppl 2006;96:130-3.
21. Petty MA, Wettstein JG. Elements of cerebral microvascular ischaemia. Brain Res Rev 2001;36:23-34.
22. Opdenakker G, Van Den Steen PE, Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol 2001;22:571-9.
23. Chandler S, Coates R, Gearing A et al. Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett 1995;201:223-6.
24. Castellanos M, Leira R, Serena J et al. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke. Stroke 2003;34:40-6.